News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
869,706 Results
Type
Article (87948)
Company Profile (826)
Press Release (780916)
Multimedia
Podcasts (194)
Webinars (28)
Section
Business (233257)
Career Advice (4146)
Deals (39876)
Drug Delivery (150)
Drug Development (91413)
Employer Resources (204)
FDA (18384)
Job Trends (17426)
News (397898)
Policy (39967)
Tag
Academia (3010)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (145)
Alliances (56981)
ALS (180)
Alzheimer's disease (1787)
Antibody-drug conjugate (ADC) (343)
Approvals (18557)
Artificial intelligence (620)
Autoimmune disease (155)
Automation (35)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (200)
Biotechnology (491)
Bladder cancer (162)
Brain cancer (65)
Breast cancer (653)
Cancer (4983)
Cardiovascular disease (437)
Career advice (3569)
Career pathing (41)
CAR-T (302)
CDC (59)
Celiac Disease (1)
Cell therapy (820)
Cervical cancer (37)
Clinical research (76953)
Collaboration (1780)
Company closure (5)
Compensation (1145)
Complete response letters (70)
COVID-19 (2989)
CRISPR (98)
C-suite (841)
Cystic fibrosis (154)
Data (6196)
Decentralized trials (2)
Denatured (71)
Depression (149)
Diabetes (529)
Diagnostics (7217)
Digital health (44)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (298)
Drug pricing (222)
Drug shortages (36)
Duchenne muscular dystrophy (236)
Earnings (100081)
Editorial (63)
Employer branding (25)
Employer resources (173)
Events (135019)
Executive appointments (1028)
FDA (21513)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1540)
Gene editing (212)
Generative AI (63)
Gene therapy (663)
GLP-1 (1114)
Government (5437)
Grass and pollen (8)
Guidances (383)
Healthcare (20942)
HIV (60)
Huntington's disease (48)
IgA nephropathy (86)
Immunology and inflammation (288)
Immuno-oncology (57)
Indications (87)
Infectious disease (3275)
Inflammatory bowel disease (203)
Inflation Reduction Act (17)
Influenza (118)
Intellectual property (242)
Interviews (816)
IPO (17954)
IRA (60)
Job creations (5199)
Job search strategy (2866)
JPM (64)
Kidney cancer (17)
Labor market (91)
Layoffs (659)
Leadership (40)
Legal (10159)
Liver cancer (98)
Longevity (14)
Lung cancer (676)
Lymphoma (375)
Machine learning (44)
Management (66)
Manufacturing (833)
MASH (172)
Medical device (15015)
Medtech (15063)
Mergers & acquisitions (22971)
Metabolic disorders (1378)
Multiple sclerosis (160)
NASH (23)
Neurodegenerative disease (351)
Neuropsychiatric disorders (95)
Neuroscience (3089)
Neurotech (1)
NextGen: Class of 2026 (7707)
Non-profit (5110)
Now hiring (64)
Obesity (664)
Opinion (333)
Ovarian cancer (166)
Pain (203)
Pancreatic cancer (230)
Parkinson's disease (293)
Partnered (39)
Patents (496)
Patient recruitment (468)
Peanut (60)
People (66853)
Pharmaceutical (145)
Pharmacy benefit managers (32)
Phase I (23785)
Phase II (33384)
Phase III (25170)
Pipeline (4841)
Policy (332)
Postmarket research (3554)
Preclinical (10688)
Press Release (72)
Prostate cancer (241)
Psychedelics (53)
Radiopharmaceuticals (298)
Rare diseases (880)
Real estate (7439)
Recruiting (80)
Regulatory (28941)
Reports (66)
Research institute (2722)
Resumes & cover letters (651)
Rett syndrome (27)
RNA editing (20)
RSV (83)
Schizophrenia (157)
Series A (256)
Series B (194)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (176)
Sponsored (48)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (112)
Tariffs (99)
The Weekly (121)
Vaccines (1140)
Venture capital (94)
Weight loss (457)
Women's health (85)
Worklife (21)
Date
Today (62)
Last 7 days (379)
Last 30 days (2120)
Last 365 days (32997)
2026 (2017)
2025 (33228)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (88)
Alaska (7)
Arizona (340)
Arkansas (14)
Asia (51526)
Australia (9045)
California (11422)
Canada (3287)
China (1149)
Colorado (484)
Connecticut (496)
Delaware (343)
Europe (118373)
Florida (1668)
Georgia (368)
Hawaii (4)
Idaho (68)
Illinois (956)
India (66)
Indiana (540)
Iowa (24)
Japan (419)
Kansas (133)
Kentucky (42)
Louisiana (29)
Maine (83)
Maryland (1448)
Massachusetts (8430)
Michigan (354)
Minnesota (662)
Mississippi (6)
Missouri (139)
Montana (35)
Nebraska (29)
Nevada (124)
New Hampshire (85)
New Jersey (3080)
New Mexico (33)
New York (3024)
North Carolina (1597)
North Dakota (10)
Northern California (5451)
Ohio (349)
Oklahoma (22)
Oregon (54)
Pennsylvania (2289)
Puerto Rico (21)
Rhode Island (50)
South America (1661)
South Carolina (64)
South Dakota (1)
Southern California (4406)
Tennessee (175)
Texas (1805)
United States (41279)
Utah (342)
Vermont (1)
Virginia (285)
Washington D.C. (87)
Washington State (960)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
There are 869,706 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Organoid : Organ or Model? Navigating the Scientific Hype - Commentary by Unexakorea
January 26, 2026
·
1 min read
Press Releases
BlueOcean Global Announces FDA 510(k) Clearance of the Excelsior™ External Fixation System
January 26, 2026
·
1 min read
Press Releases
L7 Informatics: Life Sciences Must Move from AI-Ready to AI-Actionable Execution layers are required to turn AI recommendations into governed action in regulated workflows.
January 26, 2026
·
1 min read
Mergers & acquisitions
Revolution Knows Its Worth As Merck Backs Off—For Now
Investors are apparently taking bets on when Revolution will be acquired. A handful of pharmas could be interested as Merck backs off.
January 26, 2026
·
4 min read
·
Annalee Armstrong
Press Releases
Overcoming the Wall: How Far Has BBB-Crossing Antibody Technology Truly Advanced? - Commentary by Unexakorea
January 26, 2026
·
4 min read
Duchenne muscular dystrophy
Sarepta’s DMD Gene Therapy Staves Off Disease Three Years After Treatment
After a spate of patient deaths in 2025 linked to the company’s Duchenne gene therapy, Sarepta shared new data showing benefits of the therapy three years after dosing.
January 26, 2026
·
2 min read
·
Dan Samorodnitsky
Fortrea
Ovarian cancer
Corcept’s Ovarian Cancer Drug Hits ‘Robust’ Efficacy in Phase III, Setting Up Challenge to Merck, AbbVie
Corcept’s overall survival data “look competitive” with AbbVie’s Elahere and Merck’s blockbuster Keytruda, Truist Securities said Thursday.
January 26, 2026
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Merck Backs Off Revolution After Failing To Agree on Price: WSJ
Merck had previously offered anywhere from $28 billion to $32 billion to swallow Revolution Medicines.
January 26, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Samsung Epis Holdings Reports Fourth Quarter and Fiscal Year 2025 Financial Results
January 26, 2026
·
6 min read
1 of 86,971
Next
